Aeglea BioTherapeutics, Inc.
USD12.01
+0.75 (+6.66%)
CEO
Jonathan D. Alspaugh
IPO Date
2016-04-07
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$10.87
Prev. Close
$11.26
Day Low
$10.69
Day High
$12.34
52W Low
$2.66
52W High
$24.00
Market Cap
$0.05B
Volume
0.04M
| -5.3 |
| 31 Dec 2023 | FY | 100.0% | -38238.1% | -184.1% | -99.1% | 0.00 | 10.68 | -0.4 |
| 31 Dec 2022 | FY | 100.0% | -3598.8% | -166.6% | -117.8% | 0.09 | 4.25 | -0.5 |
| 31 Dec 2021 | FY | 100.0% | -351.1% | -78.4% | -59.9% | 0.06 | 4.91 | -4.7 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -57.9% | -50.1% | 0.04 | 9.11 | -5.2 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | -130.2% | -94.1% | 0.08 | 4.06 | -3.1 |
| 31 Dec 2018 | FY | 0.0% | -1140.6% | -65.8% | -57.0% | 0.00 | 7.49 | -3.5 |
| 31 Dec 2017 | FY | 0.0% | -523.3% | -54.1% | -48.6% | 0.00 | 9.77 | -3.0 |
| 31 Dec 2016 | FY | 0.0% | -468.8% | -34.5% | -32.4% | 0.00 | 16.75 | -2.0 |
| -45.3 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -2.5% | -2.2% | 0.00 | 10.90 | -28.1 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -8.1% | -6.8% | 0.00 | 6.49 | -6.2 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -9.3% | -7.9% | 0.00 | 8.06 | -5.4 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -10.9% | -9.3% | 0.00 | 11.26 | -4.9 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -21.1% | -16.4% | 0.00 | 7.32 | -5.4 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -10.4% | -8.9% | 0.00 | 19.70 | -7.2 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -28.8% | -9.0% | 0.00 | 11.38 | -7.7 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | -34.3% | -18.5% | 0.00 | 10.68 | -1.8 |